# Triggers And Risk Factors to Develop a Reversible Cerebral Vasoconstriction Syndrome

> **NCT04179383** · NA · RECRUITING · sponsor: **University Hospital, Montpellier** · enrollment: 225 (estimated)

## Conditions studied

- Reversible Cerebral Vasoconstriction Syndrome

## Interventions

- **OTHER:** Constitution of a biobank

## Key facts

- **NCT ID:** NCT04179383
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-12-05
- **Primary completion:** 2024-06
- **Final completion:** 2024-09
- **Target enrollment:** 225 (ESTIMATED)
- **Last updated:** 2024-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04179383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04179383, "Triggers And Risk Factors to Develop a Reversible Cerebral Vasoconstriction Syndrome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04179383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*